Papers

2

Total Citations

83

H-Index

2

About

Gefei Wang is a leading clinical researcher in gastrointestinal surgery, with a primary focus on surgical site infections (SSIs) and their prevention in China. Dr. Wang’s major contributions lie in establishing the first nationwide, large-scale epidemiological data on SSIs following gastrointestinal and colorectal procedures. Their landmark 2019 multicenter prospective study, cited 48 times, provided critical baseline incidence rates for SSIs after gastrointestinal surgery across China. Building on this, their 2020 national cross-sectional study (35 citations) rigorously identified specific risk factors for SSIs after colorectal surgery, addressing a critical gap in evidence-based infection control for Chinese surgical populations. By creating these foundational databases, Dr. Wang’s work has directly informed clinical guidelines and quality improvement initiatives aimed at reducing postoperative morbidity and mortality. Their research is essential reading for surgeons, infection control specialists, and public health researchers seeking to understand and mitigate the burden of SSIs in one of the world’s largest surgical populations.

Research Focus

Key Achievements

2
H-Index
2
Papers
83
Total Citations
42
Avg Citations/Paper
🏆 Most Cited Paper
Surgical Site Infection After Gastrointestinal Surgery in China: A Multicenter Prospective Study
48 citations · 2019
📈 Most Prolific Year: 2019 (1 Papers)
🤝 Key Collaborators: 14
🏛 Institutions: Nanjing General Hospital of Nanjing Military Command

Top Papers

  1. 1
  2. 2

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago